Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Neither route is proven better in people
Retatrutide is an unlicensed investigational triple incretin receptor agonist by Eli Lilly
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
The frequency and nature of side effects can vary depending on the route of administration, with intramuscular injections occasionally producing different reactions compared to oral preparations
The dosage strength and treatment frequency also play a role in overall expenses, which can be determined during a personal consultation
US$ 26.15
US$ 28.18
US$ 24.91
US$ 28.29
